Adlai Nortye FY26 H1 net loss narrows 70.9% to US$5.3 million; revenue turns to US$13.1 million
ANL•Cash position and pipeline updates
- Cash, cash equivalents and short-term investments rose to USD 231.9 million at June 30 from USD 8.1 million at end-2025.
- Pipeline updates include Phase I enrollment for AN9025 in QD and QW arms; first AN4035 Phase I approval in Australia; initial AN9025 data expected in 1H 2027.
Half-year loss narrows as revenue turns positive
- Adlai Nortye posted a 1H 2026 net loss of USD 5.34 million, narrowing 70.9% from a year earlier; loss per share improved to USD 0.04.
- Revenue turned positive to USD 13.06 million from no revenue, entirely tied to its AN9025 license agreement with Jiangsu Aosaikang.
- R&D expense slipped 4% to USD 14.63 million, while administrative costs climbed 43.1% to USD 5.82 million on higher share-based compensation.
Related News
Boost Run Reports First Earnings As A Public Company, Reporting Second Quarter 2026 Results, Supported By $1.9 Billion Total Contract Value
BRUN•
SurgePays returns to profit in Q2 FY26; revenue rises 40.7% to $16.2 million year over year
SURG•
